Findings

What do systematic reviews say?

4,678 questions · 4,859 findings · 283 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1,225 · 25.2%GRADE not reported 215 · 4.4%Very low 1,241 · 25.5%Low 1,210 · 24.9%Moderate 776 · 16%High 192 · 4%

Summary of findings table ‐ Carer interventions vs usual care

Total nocturnal sleep time (minutes) · sleep disturbances in dementia

1 finding from 1 review

Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 33 participants
Low

Summary of findings table ‐ Carer interventions vs usual care

Consolidated sleep ‐ not measured · sleep disturbances in dementia

The review found no eligible studies for this question.

1 finding from 1 review

Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Carer interventions vs usual care

Sleep efficiency · sleep disturbances in dementia

1 finding from 1 review

Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 33 participants
Low

Summary of findings table ‐ Carer interventions vs usual care

Total wake time at night (minutes) · sleep disturbances in dementia

1 finding from 1 review

Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 33 participants
Low

Summary of findings table ‐ Carer interventions vs usual care

Number of nocturnal awakenings ‐ not reported · sleep disturbances in dementia

The review found no eligible studies for this question.

1 finding from 1 review

Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Carer interventions vs usual care

Sleep onset latency ‐ not reported · sleep disturbances in dementia

The review found no eligible studies for this question.

1 finding from 1 review

Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Carer interventions vs usual care

Adverse events · sleep disturbances in dementia

1 finding from 1 review

Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 2 participants
Moderate

Summary of findings table ‐ Physical activities vs usual care

Total nocturnal sleep time (minutes) · sleep disturbances in dementia

1 finding from 1 review

Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 167 participants
Low

Summary of findings table ‐ Physical activities vs usual care

Consolidated sleep ‐ not measured · sleep disturbances in dementia

The review found no eligible studies for this question.

1 finding from 1 review

Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Convalescent plasma vs placebo or usual care

All‐cause mortality at up to day 28 ‐ total · individuals with moderate to severe disease

Summary of findings table ‐ Convalescent plasma showed no clear difference in all‐cause mortality at up to day 28 ‐ total compared with placebo or standard care alone (high certainty).

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
RR 0.98 [0.92, 1.03]
21 studies · 19021 participants
High

Summary of findings table ‐ Convalescent plasma vs standard plasma

Quality of life, · individuals with moderate to severe disease

The review found no eligible studies for this question.

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Convalescent plasma vs standard plasma

Grades 3 and 4 adverse events · individuals with moderate to severe disease

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 248 participants
Very low

Summary of findings table ‐ Convalescent plasma vs standard plasma

Serious adverse events · individuals with moderate to severe disease

It is very uncertain whether summary of findings table ‐ Convalescent plasma changes serious adverse events compared with standard plasma (very low certainty).

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
RR 0.8 [0.55, 1.15]
3 studies · 327 participants
Very low

Summary of findings table ‐ Convalescent plasma vs human immunoglobulin

All‐cause mortality at up to day 28 · individuals with moderate to severe disease

Summary of findings table ‐ Convalescent plasma showed no clear difference in all‐cause mortality at up to day 28 compared with human immunoglobulin (low certainty).

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
RR 1.07 [0.76, 1.5]
1 study · 190 participants
Low

Summary of findings table ‐ Convalescent plasma vs human immunoglobulin

Clinical worsening: need for invasive mechanical ventilation, or death at up to day 28 · individuals with moderate to severe disease

The review found no eligible studies for this question.

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Convalescent plasma vs human immunoglobulin

Clinical improvement: participants discharged from hospital ‐ not reported · individuals with moderate to severe disease

The review found no eligible studies for this question.

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Convalescent plasma vs human immunoglobulin

Quality of life ‐ not reported · individuals with moderate to severe disease

The review found no eligible studies for this question.

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Convalescent plasma vs human immunoglobulin

Grades 3 and 4 adverse events ‐ not reported · individuals with moderate to severe disease

The review found no eligible studies for this question.

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Convalescent plasma vs human immunoglobulin

Serious adverse events ‐ not reported · individuals with moderate to severe disease

The review found no eligible studies for this question.

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Convalescent plasma vs placebo or usual care

All‐cause mortality at up to day 28 · outpatients withmild disease

It is very uncertain whether summary of findings table ‐ Convalescent plasma changes all‐cause mortality at up to day 28 compared with placebo or standard care alone (very low certainty).

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
OR 0.36 [0.09, 1.46]
2 studies · 536 participants
Very low